HKD53.90
3.14% day before yesterday
Hong Kong, Dec 27, 09:08 am CET
ISIN
CNE1000031K4
Symbol
2359
Index
Sector
Industry

WuXi AppTec Stock price

HKD53.90
+7.00 14.93% 1M
+23.85 79.37% 6M
-25.55 32.16% YTD
-23.15 30.05% 1Y
-74.20 57.92% 3Y
-4.31 7.41% 5Y
+24.99 86.43% 10Y
Hong Kong, Closing price Fri, Dec 27 2024
-1.75 3.14%
ISIN
CNE1000031K4
Symbol
2359
Index
Sector
Industry

Key metrics

Market capitalization HKD154.80b
Enterprise Value HKD147.55b
P/E (TTM) P/E ratio 15.86
EV/FCF (TTM) EV/FCF 18.46
EV/Sales (TTM) EV/Sales 3.54
P/S ratio (TTM) P/S ratio 3.71
P/B ratio (TTM) P/B ratio 2.56
Dividend yield 2.02%
Last dividend (FY23) HKD1.09
Revenue growth (TTM) Revenue growth -7.04%
Revenue (TTM) Revenue HKD41.74b
EBIT (operating result TTM) EBIT HKD10.97b
Free Cash Flow (TTM) Free Cash Flow HKD7.99b
Cash position HKD15.56b
EPS (TTM) EPS HKD3.40
P/E forward 15.18
P/S forward 3.63
EV/Sales forward 3.46
Show more

Is WuXi AppTec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

WuXi AppTec Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a WuXi AppTec forecast:

14x Buy
74%
3x Hold
16%
2x Sell
11%

Analyst Opinions

19 Analysts have issued a WuXi AppTec forecast:

Buy
74%
Hold
16%
Sell
11%

Financial data from WuXi AppTec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
41,736 41,736
7% 7%
100%
- Direct Costs 25,043 25,043
7% 7%
60%
18,905 18,905
6% 6%
45%
- Selling and Administrative Expenses 4,243 4,243
170% 170%
10%
- Research and Development Expense 1,484 1,484
14% 14%
4%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 10,967 10,967
8% 8%
26%
Net Profit 9,914 9,914
6% 6%
24%

In millions HKD.

Don't miss a Thing! We will send you all news about WuXi AppTec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Head office China
CEO Min Chen
Employees 41,116
Founded 2000
Website www.wuxiapptec.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today